Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Series C funding round

funding round1 mentionslast seen Oct 27, 2026

Preferred equity financing for up to $75,000,000 involving Series C Non-Voting Convertible Preferred Stock and warrants.

Relationships 1

Valion Bio, Inc.funded bySeries C funding round93% confidence1 source

Series C funding round

Relationship

Valion Bio, Inc.funded bySeries C funding round

93% confidence1 supporting mentionsfrom Dec 9, 2025

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 27, 2026Valion Bio, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Securities Purchase Agreement, dated as of December 9, 2025 (the "Series C Preferred Purchase Agreement"), with respect to the purchase and sale of (a) up to 75,000 shares of the Company's Series C Non-Voting Convertible Preferred Stock ("Series C Preferred Shares") and (b) warrants ("Series C Warrants")